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Summary
Objective: The purpose of the current study was to investigate the feasibility of applying defect-size femoral implants for the treatment of
localized cartilage defects in a 1-year follow-up model.
Methods: In 13 goats, a medial femoral condyle defect was created in both knees. Defects were randomly treated by immediate placement of
an oxidized zirconium (OxZr) (n¼ 9) or cobaltechromium (CoCr) implant (n¼ 9) or left untreated (n¼ 8). Six un-operated knee joints served as
a control. Animals were sacriﬁced at 52 weeks. Joints were evaluated macroscopically. Cartilage quality was analyzed macroscopically and
microscopically and cartilage repair of untreated defects was scored microscopically. Glycosaminoglycan (GAG) content, release and synthe-
sis were measured in tissue and medium. Implant osseointegration was measured by automated histomorphometry.
Results: Cartilage repair score of the defects was 13.3 3.0 out of 24 points (0¼ no repair, 24¼maximal repair). Articular evaluation scores
decreased (indicative of degeneration) in untreated defects and in defects treated with either implant (P< 0.05). Macroscopical, microscopical
and biochemical analysis showed that the presence of untreated defects and the implants caused considerable degeneration of medial tibial
plateau, and to a lesser extent of the lateral compartment. Mean bone-implant contact was extensive and not different between materials
(39.5 28.1% for OxZr and 42.3 31.5% for CoCr) (P¼ 0.873).
Conclusions: Considerable cartilage degeneration was induced in the articulating cartilage of the medial tibial plateau 1 year after creating an
osteochondral defect in the medial femoral condyle. Treating this defect with a small metal implant, made of either OxZr or CoCr, could not
prevent this degeneration. Further optimization of defect-size implants and their placement is required to make this the therapy of choice for
the treatment of local cartilage defects.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Localized cartilage defects in the knee are associated with
disability and symptoms such as joint pain, locking phenom-
ena and reduced or disturbed function. Moreover, these
defects predispose to severe forms of osteoarthritis1. The
surgical treatment of localized cartilage defects is usually
aimed at stimulation of biological repair, including subchon-
dral perforation2,3, osteochondral transplantation, and
autologous chondrocyte transplantation. Although these bi-
ological repair treatment modalities are well established4,5,
they have limitations. Often, ﬁbrous or ﬁbrocartilaginous tis-
sue is formed, which is frequently followed by progressive
joint degeneration, often resulting in an indication for further
surgical intervention, such as an osteotomy, joint distrac-
tion1, a hemiarthroplasty or a total joint replacement1.
A proposed alternative for the treatment of localized
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377implants ﬁlling the cartilage defect, thereby re-establishing
the integrity of the joint surface. Although this treatment
modality has already been applied in humans after
trauma of the knee, hip, toe and shoulder6e8, there is
no experimental evidence suggesting its efﬁcacy as an
alternative to the established surgical treatments. In fact,
in a rabbit model, defect-sized implants inserted in knee
defects were found to induce considerable cartilage
degeneration of the opposing articulating cartilage of the
tibia9,10. However, this may have been due to the sensi-
tivity of such a small animal model to small deviations
in surgery procedures. The thickness of healthy adult rab-
bit knee cartilage thickness is 0.3 mm, whereas healthy
goat knee cartilage is 0.7e1.5 mm thick11. Thus malposi-
tioning of only 1 mm or less might have fewer conse-
quences in a goat knee.
Vital in the application of non-degradable implants are
their biomechanical and wear characteristics. Currently,
cobaltechromium (CoCr) alloy is a frequently employed
material for hemiarthroplasty bearing surfaces, however,
even given the wide implementation, some downsides
are described12,13. For example, failure of CoCr hemiar-
throplasty hip prostheses was found, due to pain and ero-
sion of acetabular articular cartilage and bone14. Therefore,
378 R. J. H. Custers et al.: Treating chondral defects with implantsceramic bearing materials such as oxidized zirconium
(OxZr) have sparked renewed interest, based on in vivo
properties such as better scratch resistance, less surface
roughness after articulation against third body debris
such as bone cement, a lower friction coefﬁcient and
more elasticity, while maintaining equivalent device fatigue
strength15e21. Therefore, it could be hypothesized that this
material would be suitable as an articulating surface in
treatment of cartilage defects, joint trauma and early, local-
ized osteoarthritis using defect-sized non-degradable im-
plants. However, the postulated superiority of this
material has not been proven in vivo, where not only artic-
ulation, but also osseointegration and surgical aspects de-
ﬁne the functionality of an implant. To verify the
applicability of local implants in the treatment of cartilage
defects in a large animal model (in an effort to avoid the
propensity of small animal models for suboptimal implant
positioning) and to evaluate whether OxZr would confer
an advantage over CoCr in terms of joint and cartilage in-
tegrity and implant ﬁxation, we used an in vivo model in
which a femoral tack (similar to the abovementioned rabbit
studies) of either material was applied to a localized defect
in a goat knee joint.Materials and methodsEXPERIMENTAL DESIGNThis research was approved by the Institutional Animal Care Committee
of the Utrecht University (approval number DEC04.07.057). In thirteen adult
female Dutch milk goats, a standardized medial femoral condyle defect was
created in both knees. The defects were randomly treated with either an
OxZr (nine knees) or CoCr (nine knees) press ﬁt implant (:articulating sur-
face 5.0 mm; length 13.5 mm) or left untreated (eight knees). As a control
group, the un-operated left knees of six goats (six knees) included in a sep-
arate study were used. The experimental animals were killed 52 weeks after
surgery. Macroscopic articular evaluation was performed immediately before
creating the defect and 52 weeks after treatment. Tibial and femoral cartilage
quality was evaluated by macroscopic, microscopic, and by biochemical
analysis. After 52 weeks, implant osseointegration was measured by auto-
mated histomorphometry and defect healing of the untreated defects was
scored microscopically. All results are described as mean standard
deviation.ANIMALS
Fig. 1. A. Femoral tack implant made of CoCr (left) and OxZr (right).
The OxZr components were produced from a wrought zirconium
alloy (Zr-2.5%Nb) that was oxidized by thermal diffusion to create
a zirconia surface, which is approximately 5 mm thick, and then pol-
ished to produce an articular surface as smooth as that of the CoCr
component (Ra< 0.03 mm). The CoCr components were produced
from a cast CoCr alloy [American Society for Testing and Materials
(ASTM F75)] and polished afterwards. The threads on the implants
were designed for osseointegration. B. Technical drawing of the
implant.Thirteen adult female Dutch milk goats, aged 3.1 0.28 years and weigh-
ing 66.4 8.7 kg were used for surgery. The un-operated left knees of six
adult female Dutch milk goats aged 2.4 0.28 years and weighing
65.6 5.7 kg were used as a control group. These goats were used in a sep-
arate (unpublished) study (approval number DEC04.07.057). The number of
animals needed for this study was determined by a power analysis. The
power was 0.8 and a was 0.05. The data used for this analysis were obtained
from biochemical analysis as described previously22. Food and water was
given ad libitum. General health and care conditions were monitored by
the laboratory animal welfare ofﬁcer.IMPLANTSImplants were custom-manufactured to our design speciﬁcations by Smith
& Nephew (Memphis, TN, USA). The size of the implant was 13.5 mm
(length) by 5.0 mm (diameter-articulating surface). The articulating shape
of the implant was designed after a study on goat cadaver knees and tested
in a pilot study [Fig. 1(A, B)].SURGERYAfter acclimatizing for at least 3 weeks in the animal care facility, 1 day prior
to surgery, a topical fentanyl application bandage was given as pain medica-
tion. The goats were weighed pre-operatively. Surgery was performed on both
knees, under general inhalation anaesthesia using an isoﬂurane (2% in air)
gas mixture (Abbott Laboratories, ASTPharma, The Netherlands) preceded
by detomidine hydrochloride sedation (Pﬁzer, The Netherlands) and antibioticprophylaxis (Augmentin, GlaxoSmithKline, United Kingdom). All surgical
procedures were carried out under aseptic conditions and by the same sur-
geon (RC), who had gained speciﬁc experience in the course of a pilot study.
The medial femoral condyle was exposed through a medial parapatellar inci-
sion, without dislocating the patella. After inspecting the joint and determining
the location for implantation, a drill (diameter 5.0 mm) was used to create
a standardized full-thickness cartilage defect not penetrating the subchondral
bone layer (2.0 mm deep). To place the implant, the defect was drilled deeper
(3.0 mm) and subsequently, the implant was placed ﬂush to the surrounding
cartilage surface by tapping the implant into place using a specially designed
tamp with a polyethylene head, as previously described9,10. After insertion,
the implants were visually inspected and manually tested for ﬁxation. Follow-
ing lavage, the joint, subcutis and skin were closed in three layers using su-
tures. Additional post-operative pain relief was provided by buprenorphin
(ScheringePlough, The Netherlands). Until 5 days post-operatively, ampicillin
(Albipen, Intervet, The Netherlands) was given. Post-operatively, the goats
Table I
Modified Macroscopic Articular Evaluation Parameters as
described by O’Driscoll et al.21e23
Characteristics
1. Range of motion
a. Full 2
b. <20( 1
c. >20( 0
2. Intra-articular ﬁbrosis
a. None 2
b. Minor 1
c. Major 0
3. Appearance
a. Translucent 2
b. Opaque 1
c. Discolored/irregular 0
Total 0e6
Table II
Macroscopic cartilage score as described by Mastbergen et al.24
Medial tibial plateau
Smooth surface 0
Slightly ﬁbrillated 1
Fibrillated with shallow grooves 2
Deep sharp grooves 3
Deep sharp grooves with surrounding damage 4
Lateral tibial plateau
Smooth surface 0
Slightly ﬁbrillated 1
Fibrillated with shallow grooves 2
Deep sharp grooves 3
Deep sharp grooves with surrounding damage 4
Lateral femoral condyle
Smooth surface 0
Slightly ﬁbrillated 1
Fibrillated with shallow grooves 2
Deep sharp grooves 3
Deep sharp grooves with surrounding damage 4
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weeks, the animals were weighed and euthanized using an overdose of
pentobarbital (Euthesate).RADIOGRAPHSPre-operatively, ﬂuoroscopy was applied in an anterioreposterior and
a mediolateral direction to conﬁrm the normal anatomy and the size of the
bone. Immediately post-surgery, the positioning of each implant was visual-
ised and possible surgical complications such as fractures were examined.
After sacriﬁce of the animals (52 weeks), the joints were checked for implant
malpositioning (depressed or elevated compared to the surrounding carti-
lage), loosening (sclerotic zones and radiolucency surrounding the implant),
and movement from the original position, or other complications (such as
fractures).GENERAL MACROSCOPIC ARTICULAR EVALUATIONAfter opening of the joint space prior to creation of the defects (¼healthy
joint) and application of the treatments, as well as post-mortem, the joint
was inspected blinded to the animal and treatment and evaluated by two
observers (RC & MvR) according to the guidelines as described by O’Dris-
coll23e25. Since it was not possible to score the ‘restoration of contour’ and
‘cartilage erosion of the graft’ for the implant groups, the Macroscopic Artic-
ular Evaluation Parameters were modiﬁed (scores 0e6 instead of 0e10)
(Table I).MACROSCOPIC SCORING OF ARTICULAR CARTILAGE
COMPARTMENTSAfter removal of soft tissues, macroscopic evaluation as described by
Mastbergen et al.26 was performed by two observers (RC & MvR) on coded
high-resolution photographs for each compartment separately (blinded to the
source of the photograph, the medial plateau, directly in contact with the de-
fect/implant and the lateral plateau and condyle, as part of the knee joint, but
not directly in contact with the defect/implant). This scoring system evaluates
the cartilage surface (Table II). The scores of the two observers were aver-
aged and outliers with a difference of more than one point were scored again,
until consensus was reached. The higher the score, the more the cartilage is
damaged.CARTILAGE EXPLANTS HARVESTFig. 2. Scheme showing the areas of sample harvesting.Upon sacriﬁce, cartilage tissue samples were obtained from predeﬁned
locations under aseptic conditions (Fig. 2). First, two full-thickness cartilage
tissue explants were cut from the underlying subchondral bone layer, one
just anterior and one just posterior from the most weight-bearing area of
each femoral condyle and tibial plateau. Subsequently, each cartilage
explant was cut into three or ﬁve separate pieces (depending on location), of
which two or four were used for biochemical assays, respectively. One piece
was used for histology (the most peripheral one). Furthermore, full cross-sec-
tional osteochondral explants were harvested for histology from the middle of
each location (medial and lateral tibial plateau, and medial and lateral femoral
condyle), including the defect area or containing the implant.MICROSCOPIC CARTILAGE EVALUATIONImmediately after harvesting, all tissue explants used for microscopic analy-
sis were ﬁxed in 10% buffered formalin during 48 h. Subsequently, all osteo-
chondral tissue explants were decalciﬁed using Luthra’s solution (3.2% 11 M
HCl, 10% formic acid in distilled water) over 48 h. Non-decalciﬁed and decalci-
ﬁed tissues were then dehydrated via 70%e100% ethanol, immersed in xylene
and embedded in parafﬁn. Embedded tissues were cut into 5 mm thick parafﬁn
sections and stained with Safranin-O and fast green according to the Osteoar-
thritis Research Society International (OARSI) guidelines27. The histological
sections were blinded and presented at random to two observers (RC & MvR).
Osteochondral sections from the entire lateral femoral condyle and the tib-
ial plateau from medial to lateral were evaluated using the OARSI Osteo-
arthrtis Cartilage Histopathology Assessment System (OOCHAS)27,28 to
determine the degree of cartilage degeneration for each location separately.
A score of 0 represents normal cartilage, whereas a score of 24 represents
Table IIIA
OARSI Osteoarthritis Cartilage Histopathology Assessment System e Advanced grading methodology-as described by Pritzker et al.25,26
First, the grade is determined, then the stage, and finally, the grade is multiplied by the stage resulting in the final score
Grade (key feature) Subgrade (optional) Associated criteria (tissue reaction)
Grade 0: surface intact,
cartilage intact
No subgrade Intact, uninvolved cartilage
Grade 1: surface intact 1.0 Cells intact
1.5 Cell death
Matrix: superﬁcial zone intact, oedema and/or ﬁbrillation
Cells: proliferation (clusters), hypertrophy
Reaction must be more than superﬁcial ﬁbrillation only
Grade 2: surface
discontinuity
2.0 Fibrillation through superﬁcial zone
2.5 Surface abrasion with matrix loss within
superﬁcial zone
As above
þ Discontinuity at superﬁcial zone
 Cationic stain matrix depletion (Safranin-O or Toluidine Blue)
upper 1/3 of cartilage (mid zone)
 Disorientation of chondron columns
Grade 3: vertical
ﬁssures
3.0 Simple ﬁssures
3.5 Branched/complex ﬁssures
As above
 Cationic stain depletion (Safranin-O or Toluidine Blue) into
lower 2/3 of cartilage (deep zone)
 New collagen formation (polarized light microscopy, Picro
Sirius Red stain)
Grade 4: erosion 4.0 Superﬁcial zone delamination
4.5 Mid zone excavation
Cartilage matrix loss, cyst formation within cartilage matrix
Grade 5: denudation 5.0 Bone surface intact
5.5 Reparative tissue surface present
Surface is sclerotic bone or reparative tissue including
ﬁbrocartilage
Grade 6: deformation 6.0 Joint margin osteophytes
6.5 Joint margin and central osteophytes
Bone remodeling. Deformation of articular surface contour
(more than osteophyte formation only) Includes: microfracture
and repair
Grade¼ depth progression into cartilage.
Table IIIB
OARSI Osteoarthritis Cartilage Histopathology Assessment
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were also scored for the degree of ﬁlling of the untreated cartilage defects,
blinded, at random by two different observers (RC & MvR) using the criteria
suggested by O’Driscoll23,24 (Table IV).
In addition, the Histological/Histochemical Grading System (HHGS)29 was
applied to the non-decalciﬁed cartilage explants. Since in the latter explants
bone was not included, the tidemark between cartilage and bone was not
present. Moreover, due to the dissection method, pannus could not be dem-
onstrated on the cartilage explants. Therefore, the maximum score that could
be obtained was 11 instead of the 14, due to the omission of criteria ‘pannus’,
‘clefts to calcified zone’, and ‘tidemark crossed by blood vessels’ as
described previously30 (Table V).System e Stage assessment-as described by Pritzker et al. First,
the grade is determined, then the stage, and finally, the grade is
multiplied by the stage resulting in the final score25,26BIOCHEMICAL CARTILAGE EVALUATIONStage % Involvement (surface, area, volume)
Stage 0 No OA activity seen
Stage 1 <10%
Stage 2 10e25%
Stage 3 25e50%
Stage 4 >50%
Stage¼ extent of joint involvement.
Table IIIC
OARSI Osteoarthritis Cartilage Histopathology Assessment
System e Scoring, semi-quantitative method-as described byFor femoral condyles and tibial plateaus, cartilage proteoglycan (PG) con-
tent, synthesis, and release were determined of respectively eight and 16 ex-
plants obtained from predeﬁned locations. Two to four full-thickness cartilage
slices, anterior and posterior from themost weight-bearing area, wereweighed
aseptically (range 5e20 mg) and cultured individually in 96-well round-bottom
microtiter plates. Explantswere cultured inDulbecco’sModiﬁedEagleMedium
(DMEM; Gibco 074-01600, 0.81 mM SO4
2, 24 mM NaHCO3) supplemented
with ascorbic acid (85 mM), glutamine (2 mM), penicillin (100 IU/ml), strepto-
mycin sulfate (100 mg/ml), and 10% pooled goat serum at 5%CO2, and 37
C
(all from: Gibco, New York, USA). Ex vivo PG synthesis was determined at
day 0 by measuring 35SO4
2 incorporation and implants were incubated for
a subsequent 3-day period in the absence of label to determine PG release
and PG content. Conditioned medium and cartilage samples were stored at
20C until analysis.Pritzker et al. First, the grade is determined, then the stage, and
finally, the grade is multiplied by the stage resulting in the
25,26PG SYNTHESIS final score
Grade Stage
S1 S2 S3 S4
G1 1 2 3 4
G2 2 4 6 8
G3 3 6 9 12
G4 4 8 12 16
G5 5 10 15 20
G6 6 12 18 24
Score¼ grade stage.PG synthesis was determined by measuring 35SO4
2 incorporation into
glycosaminoglycans (GAGs) in the presence of 10 mCi/ml of 35SO4
2
(Na2
35SO4, carrier-free, NEX-041-H; DuPont, The Netherlands). Four hours
after the addition of 35SO4
2, the samples were washed three times for
45 min in fresh culture medium (37C) and cultured for another 3 days. Con-
ditioned medium was collected and frozen at 20C until analysis. Cartilage
samples were digested in 3% papain buffer (dissolved in 0.5 M phosphate
buffer, 20 mM N-acetylcysteine and 20 mM Na2-EDTA, pH6.5) at 65
C for
2 h. Papain digests were diluted to the appropriate concentrations for analy-
sis of PG synthesis rate and PG content/release as well as DNA content.
35SO4
2 incorporation into GAGs was measured by liquid scintillation
counting (Tri-carb 1900CA, Packard, USA) of cartilage papain digests and
conditioned medium. The sum of 35SO4
2 radioactivity in the cartilage digestsand conditioned medium after 3 days of culturing represented 35SO4
2 incor-
poration on day 0. The rate of 35SO4
2 incorporation was expressed as nmoles
of 35SO4
2 incorporated per hour per gram wet weight of the cartilage tissue.PG CONTENT AND RELEASEAlcian Blue (A-5268; Sigma) precipitation of GAGs in the papain digests
and conditioned medium was determined as a parameter for total PG
Table IV
Cartilage repair score as described by O’Driscoll et al.21,22
Characteristics Score
Nature of predominant tissue
Cellular morphology
Hyaline articular cartilage 4
Incomplete differentiated mesenchyme 2
Fibrous tissue or bone 0
Safranin-O staining of the matrix
Normal or nearly normal 3
Moderate 2
Slight 1
None 0
Structural characteristics
Surface regularity
Smooth and intact 3
Superﬁcial horizontal lamination 2
Fissures 25e100% of the thickness 1
Severe disruption, including ﬁbrillation 0
Structural integrity
Normal 2
Slight disruption, including cysts 1
Severe disintegration 0
Thickness
100% or normal adjacent cartilage 2
50e100% of normal cartilage 1
0e50% of normal cartilage 0
Bonding to adjacent cartilage
Bonded at both ends of graft 2
Bonded at one end, or partially at both ends 1
Not bonded 0
Freedom from cellular changes of degeneration
Hypocellularity
Normal cellularity 3
Slight hypocellularity 2
Moderate hypocellularity 1
Severe hypocellularity 0
Chondrocyte clustering
No clusters 2
<25% of the cells 1
25e100% of the cells 0
Freedom from degenerative changes in adjacent cartilage
Normal cellularity, no clusters, normal staining 3
Normal cellularity, mild clusters, moderate staining 2
Mild or moderate hypocellularity, slight staining 1
Severe hypocellularity, poor or no staining 0
Total 0e24
Table V
Modified HHGS as described by Mankin et al.27, and modified by
Lafeber et al.28
I Structure A Normal 0
B Surface irregularities 1
C Clefts to transitional zone 2
D Clefts to radial zone 3
E Complete disorganization 4
II Cells A Normal 0
B Diffuse hypercellularity 1
C Cloning 2
D Hypocellularity 3
II Safranin-O staining A Normal 0
B Slight reduction 1
C Moderate reduction 2
D Severe reduction 3
E No dye noted 4
Total score
Minimal 0
Maximal 11
381Osteoarthritis and Cartilage Vol. 18, No. 3content and release, respectively. Staining for GAG was measured as the
change in absorbance at 620 nm using chondroitin sulphate (C4383;
Sigma-Aldrich, The Netherlands) as a reference. Results are expressed
as mg GAG per gram wet weight of the cartilage explants and the initial
GAG content on day 0 was calculated from the total amount of GAG re-
leased into the medium and the total GAG content of the explants after
72 h.EVALUATION OF BIOCOMPATIBILITY AND
OSSEOINTEGRATIONAfter 48 h of ﬁxation in 10% buffered formalin, medial femoral condyle tis-
sue slices containing the implants were dehydrated via 70e100% ethanol,
and embedded in polymethylmethacrylate. Approximately 10e20 mm thick
sections were sawed in a longitudinal direction through the middle of the
implant using the Leica SP1600 Saw Microtome system and subsequently
stained with methylene blue/basic fuchsin. Histomorphometry was
performed with a personal computer (PC)-based system equipped with the
KS400 version 3.0 software (Carl Zeiss Vision, Germany) as described pre-
viously9,10. In short, the percentage of bone surrounding the implant within
a ﬁxed distance from the implant surface was calculated and the percentage
of the implant circumference in contact with bone was determined.STATISTICAL ANALYSISValues are given as mean and standard deviation. Since there was more
than one tissue sample analyzed per location for the histological and bio-
chemical analysis, the mean of those scores per location were used as
one statistical unit. For the macroscopic scoring of articular cartilage com-
partments, a general linear model with repeated measurements was per-
formed. For the analysis of the general macroscopic articular evaluation,
the histologic and biochemical cartilage scores, each treatment group was
analyzed separately, using a general linear model with repeated measure-
ments and a split ﬁle layered by group since there was an interaction be-
tween the treatment group and location. For the differences between the
treatment groups per location, a one-way analysis of variance (one-way AN-
OVA) was performed. For the analysis of the histomorphometry a paired Stu-
dent’s t-test was performed since an intra-animal comparison could be made.
All results were corrected for multiple testing using a Bonferroni-correction,
for each analysis separately. For all analyses, P< 0.05 was deﬁned as
statistical signiﬁcant difference.ResultsSURGERY AND ANIMAL HEALTHPre-operatively, ﬂuoroscopy conﬁrmed normal knee joint
anatomy for all goats. Surgery was performed with one
major complication: one goat developed an intra-articular
infection surrounding a CoCr implant and was euthanized
after 3.5 months. This goat (CoCr and OxZr implant) was
excluded from further analysis. All other goats were able
to load their limbs and move the knees without any limita-
tions. The goats showed a maximal weight loss (at the low-
est level) of 5.5 1.3% (n¼ 12) after surgery. At the end of
the 52-weeks follow-up period, all implants were mechani-
cally stable and were located in their original position
(Fig. 3). Fluoroscopy showed no signs of malpositioning,
loosening or other complications (Fig. 4).GENERAL MACROSCOPIC ARTICULAR EVALUATIONThe pre-operative scores did not differ from the un-oper-
ated healthy knee joints (Fig. 5). Upon sacriﬁce, 52 weeks
after creating the defect or inserting the implants, the scores
had decreased signiﬁcantly in all three operated groups
compared to pre-operative and the un-operated healthy
knee joints. The reduced scores resulted from some
decrease in range of motion, minor intra-articular ﬁbrosis
Fig. 3. Examples of the medial femoral condyle after 52 weeks of follow-up. A. Untreated defect. Note the repair tissue and cartilage degen-
eration surrounding the defect area. B. OxZr implant. Some cartilage tissue has covered the implant surface. Note that the implant is
surrounded by relatively healthy cartilage. C. CoCr implant. The implant is surrounded by relatively healthy cartilage.
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observed between the untreated defects and defects
treated with either implant.MACROSCOPIC EVALUATION OF ARTICULAR
COMPARTMENTSFifty-two weeks after surgery, the knees with untreated
defects, OxZr and CoCr implants had higher macroscopicFig. 4. Examples of ﬂuoroscopy of goat knees post-mortem. AeB. Health
fect. Note that the defect area is not visible on these ﬂuoroscopy image
weight-bearing area of the femoral condyle. Some radiolucency can be
Note that this implant is placed correctly andscores (ranging from ﬁbrillated with shallow grooves to
deep sharp grooves) at the medial tibial plateau compared
to the healthy knee joints (Fig. 6). The lateral compartment
(lateral tibial plateau and lateral femoral condyle) was only
slightly ﬁbrillated for all groups. In the knees treated with
a CoCr implant, degeneration of the lateral plateau was
more pronounced compared to the untreated control
knees.y control knee. No abnormalities are observed. CeD. Untreated de-
s. EeF. OxZr implant. Note that the implant is placed in the most
seen surrounding the threads of the implant. GeH. CoCr implant.
that no radiolucency can be observed.
Fig. 5. The modiﬁed Macroscopic Articular Evaluation Parameters
(mean standard deviation). A score of six represents a healthy
joint, whereas a score of 0 represents a severely degenerated,
ﬁbrillated, and ﬁxated knee joint. The un-operated joints (long
dashed line) are considered the healthy joints. The mean score
of the joints immediately before creating the defect represents the
pre-operative value (long line). The mean score of the modiﬁed
Macroscopic Articular Evaluation Parameters was 5.8  0.4
(n¼ 6) for the un-operated healthy joints and 5.7 0.5 (n¼ 24)
pre-operatively for the operated knee joints (untreated defect,
OxZr, and CoCr) (P¼ 0.44). Upon sacriﬁce, 52 weeks after creating
the defect or inserting the implants, the scores had decreased
signiﬁcantly for all three operated groups to 4.4 0.5 (n¼ 8) for
the untreated defects (P¼ 0.009); 4.1 0.8 (n¼ 8) for the OxZr
implants (P ¼ 0.009); 4.1  0.8 (n ¼ 8) for the CoCr implants
(P¼ 0.015). No differences were observed between the untreated
defects and defects treated with either implant (vs OxZr P¼ 0.48;
vs CoCr P¼ 0.66).
383Osteoarthritis and Cartilage Vol. 18, No. 3MACROSCOPIC CARTILAGE REPAIR SCOREFig. 7. Safranin-staining of an untreated cartilage defect and a basic
fuchsin and eosin staining of the sections including an implant. A.
Histological example of an untreated defect after 52 weeks of fol-
low-up. B. Histological example of an OxZr implant 52 weeks after
implantation. The implant is positioned superior compared to theAs determined by the Cartilage Repair Score, the healing
of the untreated defects was only partly achieved [Fig. 7(A)].
The average score was 13.3 3.0 (n¼ 8) out of the maxi-
mum of 24 points.adjacent cartilage. This might be due to mispositioning, but could
also be accounted for by cartilage degeneration surrounding the im-
plant. C. Histological example of a CoCr implant 52 weeks afterMICROSCOPIC CARTILAGE EVALUATIONimplantation.According to the OOCHAS scores of the osteochondral
samples, all compartments showed slight (intact surface
with hypertrophy and/or oedema) to moderate (simple toFig. 6. Macroscopic cartilage score 52 weeks after surgery (mean -
 standard deviation). The scores of the un-operated knee joints
(n¼ 6) are represented by the white bars (control). 52 weeks after
surgery, the untreated defects (n ¼ 8), OxZr (n ¼ 8) and CoCr
(n¼ 8) implants had higher scores (ranging from ﬁbrillated with
shallow grooves to deep sharp grooves) at the medial tibial plateau
compared to the untreated healthy knee joints (* control vs
untreated defect P ¼ 0.032, vs OxZr P < 0.001, vs CoCr
P¼ 0.002). The lateral compartment (lateral tibial plateau and
lateral femoral condyle) was only slightly ﬁbrillated for all groups.
The lateral plateau was more degenerated after inserting a CoCr
implant compared to the untreated control knees (* P¼ 0.01)complex ﬁssures with PG washout) cartilage degeneration
(Fig. 8). In general, the lower scores included mild PG
washout and minor ﬁssures, whereas the higher scores in-
cluded moderate PG washout (i.e., less intense Safranin-O
staining) and moderate ﬁssures. Fibrillations were rarely
seen. The medial tibial plateau was signiﬁcantly more de-
generated after articulating against the untreated defect or
either implant compared to the un-operated healthy knee
joints (Fig. 9). The OOCHAS scores did not differ signiﬁ-
cantly between treated and untreated defects for cartilage
of the lateral tibial plateau and the lateral femoral condyle.
Analysis of the HHGS scores of the cartilage samples
taken from locations anterior and posterior from the most
weight-bearing area of all cartilage surfaces revealed that
all compartments showed slight degeneration (surface ir-
regularities with slight reduction of Safranin-O staining)
without differences between treatments (Fig. 10).PG CONTENT AND RELEASEThe GAG content (in mg/mg of wet weight) at the medial
tibial plateau and the lateral femoral condyle was higher in
cartilage explants harvested from knees with untreated
defects and either implant compared to the healthy un-oper-
ated joints [Fig. 11(A)]. No differences were seen at the
Fig. 8. Histological examples of Safranin-O/fast green stained sec-
tions of tibial plateaus. A. Medial tibial plateau directly articulating
an untreated defect. Note the cartilage degeneration (ﬁssures,
loss of matrix, and loss of staining). B. Lateral tibial plateau. The
medial tibial plateau was articulating an OxZr implant. Note the
small ﬁssures and surface irregularities. C. Histological section of
medial tibial plateau directly articulating a CoCr implant. Note the
cartilage degeneration (ﬁssures, loss of matrix, and loss of
staining).
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72 h of culturing was signiﬁcantly higher at the lateral tibial
plateau and the medial femoral condyle in the untreated
defects and either implant compared to the healthy un-oper-
ated joints [Fig. 11(B)]. No differences were seen at the
other locations in the joint.Fig. 9. OOCHAS microscopic score of osteochondral tissue explants (mea
whereas a score of 24 represents a severely degenerated joint surface. A
the un-operated (control) group (n¼ 6) at the medial tibial plateau, represe
vs CoCr P¼ 0.045). The lateral compartment also showed mild degener
(all P> 0.METABOLIC CARTILAGE ACTIVITY35SO4
2 incorporation showed signiﬁcantly less incorpora-
tion at the lateral tibial plateau and the medial femoral
condyle for the untreated defects and either implant com-
pared to the un-operated healthy joints [Fig. 11(C)]. The
other locations did not show any differences between
treatments.BIOCOMPATIBILITY AND OSSEOINTEGRATIONTwo implants had subsided (1OxZr and 1CoCr) and
were surrounded partly by bone and ﬁbrous cartilaginous
tissue. All other implants were ﬁrmly ﬁxed in the bone
[Fig. 7(B, C)]. Inﬂammatory responses were not seen
(Fig. 12).Discussion
This study shows that the cartilage degeneration caused
by a critical size untreated cartilage defect in the knee joint
could not be prevented by our application of small OxZr and
CoCr implants into these cartilage defects. This was illus-
trated both macroscopically and microscopically. Macro-
scopic joint evaluation demonstrated an increase of joint
degeneration after either surgery, regardless whether the
created defects were treated by either implant or not at
all. Similar results were seen in the macroscopic cartilage
surface scores, where the medial tibial plateau, directly ar-
ticulating against the untreated defect or the implants, was
signiﬁcantly degenerated. This was also conﬁrmed by his-
tology of cartilage explants from the most weight-bearing
area of the medial tibial plateau. Histology from locations
more anterior and posterior from the most weight-bearing
area of all cartilage surfaces did not show any differences
between the operated and non-operated joints. Further-
more, the lateral compartment was slightly degenerated
as well, albeit less than the medial compartment. This grad-
ual decrease in cartilage quality of adjacent areas was
found before9,10 and may be due to generalised intra-artic-
ular changes occurring as a consequence of local damage
and negatively affecting more remote areas22.n standard deviation). The score of 0 represents normal cartilage,
ll operated knees joints (n¼ 24) showed higher scores compared to
nted by * (control vs untreated defect P¼ 0.032, vs OxZr P¼ 0.023,
ation, however, this was similar to the un-operated (control) group
05).
Fig. 10. HHGS microscopic scores of cartilage explants taken from locations anterior and posterior from the most weight-bearing area of all
cartilage surfaces (mean standard deviation). There were no differences between the untreated healthy (control) knees (n¼ 6) and the
operated knees 52 weeks after the creation of a defect (n¼ 8) or inserting an OxZr (n¼ 8) or CoCr (n¼ 8) implant (all P> 0.05).
385Osteoarthritis and Cartilage Vol. 18, No. 3Although macroscopical and microscopical analyses re-
vealed distinct signs of cartilage degeneration, the bio-
chemical data on PG turnover were inconclusive, maybe
because of biochemical variety within a single joint, due to
different cartilage thickness and loading. In line with the
macroscopic and microscopic results, cartilage degradation
in the knees with treated and untreated defects was higher
and synthetic activity was lower compared to un-operated
knees. However, the GAG content was higher at the
medial tibial plateau and the lateral femoral condyle of the
untreated defects and either implant compared to the
un-operated control knees.
Two of the sixteen analyzed implants were surrounded by
ﬁbrocartilaginous tissue, showed a subsidence and had
only a very limited amount of bone-implant contact
(3e5%). The other thirteen implants showed a good os-
seointegration and high bone-implant contact (40e60%).
Previously, rabbit studies showed similar bone-implant con-
tact percentages ranging from 36 4%31 to 47.5 4.7%9
and 63.2 3.2%10.
This study was designed to evaluate the long-term effects
of treating a localized ‘‘fresh’’ cartilage defect in the knee
joint with a small metal implant. However, it has been de-
scribed that a disturbed intra-articular environment, caused
by one or more cartilage defects, negatively inﬂuences car-
tilage repair30. Recently, we published a goat study were
the same OxZr implants were compared to microfracture
in an established defect model32. A cartilage defect was
created and after 10 weeks treated with either an OxZr im-
plant or microfracturing with a follow-up period of 6 months.
Both microfracture and the use of implants caused signiﬁ-
cant degeneration in the directly articulating cartilage as
well as in more remote sites in the knee. However, metal
implants caused less damage to the articulating cartilage
than the marrow stimulation/microfracturing technique. To
what extent this is due to the shorter follow-up or the imme-
diate treatment of the defect is not clear. The investigators
of another goat study concerning similarly shaped implants
concluded that the extent of the tissue damage was propor-
tional to any elevation of the prosthesis above the adjacent
cartilage surface33. They used an implant system that en-
sured accurate positioning of the implant, using custom-
made implants shape-matched to the adjacent articular
contour (measured at ﬁve locations). Although theseauthors proposed positioning the surface of the prosthesis
with its entire perimeter sunken 1 mm below the adjacent
cartilage surface, we previously found in a rabbit study
that positioning the implant ﬂush induces less tibial cartilage
damage compared to placing them 1 mm below the sur-
rounding cartilage surface9. Another in vitro study showed
that elevated implantation results in increased peak contact
pressure and might be biomechanical disadvantageous in
an in vivo application34. Altogether, this importance of im-
plant placement has implications for surgical practice,
where precision is highly dependent on the individual sur-
geon’s skills and experience. The implants used in the rab-
bit9 and the current goat study are relatively small
compared to the size of the implants used in the former
goat study33. It is possible that smaller implants load more
focally than a larger implant and should therefore be placed
ﬂush, whereas a larger implant does not. Currently, only few
studies are available about clinical application of metal im-
plants used for cartilage replacement35,36.
The drawback of performing surgery on both knees is
that the treatment of one knee might inﬂuence the out-
come of the treatment of the contralateral knee. However,
the intra-animal comparison results in fewer animals
needed for the study. No sham-operated animals without
defects were included in the study. However, previous
rabbit and larger osteoarthritis (OA) model studies includ-
ing sham-operated animal groups did not reveal any car-
tilage damage, even at shorter time intervals, suggesting
that this is not likely to be a confounder in the current
study37e39. As controls, un-operated knees were included
in this study. Due to ethical considerations, these knees
were obtained from goats that were used in a separate
study where the medial tibial plateau of the contralateral
knee was replaced by a CoCr implant. Therefore, this im-
plant might have affected the quality of the analyzed con-
tralateral ‘healthy’ knee due to increased weight bearing.
However, by macroscopic articular evaluation, no evi-
dence of difference was found for the un-operated control
knees compared with the knees about to receive un-
treated defects or implant treatment. Moreover, any in-
creased weight bearing for the un-operated knees used
as controls in this study would have yielded worse rather
than better cartilage quality compared to cartilage from
completely untreated animals.
Fig. 11. GAG content (A), release (B), and synthesis (C) of explants taken from locations anterior and posterior from the most weight-bearing
area (mean standard deviation). Swelling is one of the ﬁrst features in cartilage degeneration, indicating collagen damage. In turn this leads
to a loss of tensile properties and to a loss of PGs (i.e., lower PG content, higher release), which is accompanied by an attempt to repair the
cartilage (i.e., increased synthesis). (A) At the medial tibial plateau and the lateral femoral condyle, a signiﬁcantly lower GAG content (repre-
sented by *) was measured (medial tibial plateau: control (n¼ 6) vs untreated defect P¼ 0.080 (n¼ 8); vs OxZr P¼ 0.012 (n¼ 8); vs CoCr
P¼ 0.003 (n¼ 8)); lateral femoral condyl: control (n¼ 6) vs untreated defect P¼ 0.001 (n¼ 8); vs OxZr P ¼ 0.012 (n ¼ 8); vs CoCr
P¼ 0.010 (n¼ 8); No differences were seen at other locations in the joint. (B) At the lateral tibial plateau and the medial femoral condyle,
a signiﬁcantly lower GAG release was measured in the un-operated healthy knee joints compared to the untreated defect and either implant
(* lateral tibial plateau: control (n¼ 6) vs untreated defect P¼ 0.010 (n¼ 8); vs OxZr P¼ 0.002 (n¼ 8); vs CoCr P¼ 0.023 (n¼ 8); medial
femoral condyle: control (n¼ 6) vs untreated defect P¼ 0.001 (n¼ 8); vs OxZr P< 0.0001 (n¼ 8); vs CoCr P¼ 0.018 (n¼ 8)). No differences
were seen at the other locations in the joint. (C) At the lateral tibial plateau and the medial femoral condyle, a signiﬁcantly higher 35SO4
2
incorporation (represented by *) was measured in the un-operated healthy knee joints compared to the untreated defect and either implant
(lateral tibial plateau: control (n¼ 6) vs untreated defect P¼ 0.003 (n¼ 8); vs OxZr P¼ 0.025 (n¼ 8); vs CoCr P¼ 0.045 (n¼ 8); medial
femoral condyle: control (n¼ 6) vs untreated defect P¼ 0.008 (n¼ 8); vs OxZr P¼ 0.46 (n¼ 8); vs CoCr P¼ 0.47 (n¼ 8)). The other locations
did not show any differences between treatments.
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Fig. 12. Bone histomorphometry results of stained histological sec-
tions of the OxZr and CoCr implants (mean standard deviation).
Bone-implant contact was 39.5  28.1% for OxZr (n ¼ 8) and
42.3  31.5% for CoCr (n ¼ 8) , which was not d i f ferent
(P¼ 0.873). Bone formation was 51.0  11.4% for OxZr (n¼ 8)
and 51.1  16.2% for CoCr (n ¼ 8), which was not different
(P¼ 0.992).
387Osteoarthritis and Cartilage Vol. 18, No. 3Conclusions
Altogether, considerable cartilage degeneration was
induced in the articulating cartilage 1 year after creating
a cartilage defect in the medial femoral condyle. Inserting
a small metal implant in this defect, made of either CoCr
or OxZr, could not prevent this degeneration. Therefore,
further development and ﬁne-tuning of the application of de-
fect-size implants is required to make this the therapy of
choice for the long-term treatment of local cartilage defects.Conﬂict of interest
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